Congenital lactic acidosis with neurological symptoms may be due to a variety of disorders of energy metabolism. We investigated whether positron emission tomography (PET) and proton magnetic resonance spectroscopy ('H MRS) are capable of demonstrating specific changes to facilitate diagnosis. A corresponding increase of cerebral lactate (with MRS) and rate of glycolysis (with PET) was observed in 2 children with biochemical evidence of defective mitochon drial respiration. No such increase was noted in a child with lactic acidosis due to stress and exercise but normal respiratory chain activity, and in a control case with an epilepsy syndrome without evidence of primary changes of energy metabolism. The results suggest that defects of oxidative phosphorylation may cause a massive increase of glycolysis to cover energy requirements, with corresponding accumulation of lactate in brain tissue. This mechanism can now be demonstrated in vivo and, with further experience, may potentially be used as a diagnostic marker of respiratory chain disorders in brain tissue.
Congenital lactic acidosis (CLA) is a symptom that can occur as a result of an inborn error in the pathway responsible for the metabolism of pyruvate. Common etiologies include defects of the pyruvate dehydroge nase complex, pyruvate carboxylase, mitochondrial re spiratory chain enzymes, or the Krebs cycle {1, 2]. The accompanying clinical signs and symptoms may vary considerably depending on the type and the severity o f defect. Diagnosis is usually based on biochemical, radiological, and pathological studies. However, evalu ation is often invasive, time consuming, and is not al ways conclusive.
Positron emission tomography (PET) has been used in the evaluation of mitochondrial diseases because it provides a quantitative tracer method for regional mea surements of glucose and oxygen metabolism in brain tissue as well as blood flow. A study using 2fluoro-2-deoxyglucose (FDG), [ 150 ] oxygen, and [ 150 ] carbon dioxide in a series of adult patients with mito chondrial encephalomyopathy showed an altered stoichiometry in glucose and oxygen utilization resulting from aerobic glycolysis to lactate {3}. A similar study 4 examining patients with a clinical phenotype of CLA known bv the acronvm MERRF for myoclonus lepsy and ragged-red fibers [4] , however, revc signs of increased aerobic glycolysis. These found a chronically low rate of oxidative metabolism [5] . An adult patient with a mitochondrial encephalo-» A myopathy (probable MERRF) also showed a decrease in the cerebral metabolic rate of glucose (CMRa{[.) [6] be in the examination of normal and abnorm _*nt is image-g proton magne tic resonance spectroscopy (lH MRS). The infor mation obtained from localized proton MR spectroscopy can supplemented by information on spatial distribution of metabolites using 1H MR speo troscopic imaging (SI). In several studies [7] [8] [9] [10] in creased peaks for lactate have been described in chil dren with Leigh disease [11] , a form of CLA that can be caused by a defect in oxidative phosphorylation or pyruvate metabolism.
FDG PET and lH MRS are complementary with regard to investigating the rate of glycolysis. The for mer basically measures the rate of FDG phosphoryla tion by hexokinase, which is nearly irreversible and therefore reflects total, oxidative and nonoxidative, gly colytic activity; the latter assesses lactate, which is the principal product of nonoxidative glycolysis. We there fore performed both, FDG PET and *H MRS, for di rect comparison of glycolytic rates and lactate levels in 4 children, 2 of whom had biochemical evidence of impaired mitochondrial respiration. [14] and Korenke and associates [15] . EXACT 921) with 6-mm transaxial and 5-mm axial resolu tion. After a rapid intravenous bolus injection of FDG (3.7-7.4 MBq/kg of body weight), patients were scanned for a total period of 50 to 60 minutes in a dimly lit room with low ambient noise. Images were recorded with the 7-slice scanner in two table positions from 30 to 40 and 40 to 50 minutes after injection, respectively, yielding a total of 14 slices comprising nearly the entire brain; whereas with the 47-ring scanner, the whole brain was assessed without chang ing the table position from 20 to 60 min. Plasma activity was measured in multiple arterial blood samples. CMR^c was calculated pixel by pixel with rate constants K\ and ad justed to measured tissue activity [17] , and a fixed lumped constant value of 0.42.
Materials and M ethods

Mitochondrial Studies
All images were initially analyzed visually. Each image was then coregistered three-dimensionally to a reference PET im age in standard position (transaxial plane parallel to the intercommissural line) using a multipurpose match program [18] with striatum and thalamus as major landmarks. Regions of interest (ROIs) were placed on multiple transaxial slices using a PC adaptation of an interactive mapping program [19] , guided by the atlas of Matsui and Hirano [20] , and CMR"k was calculated for major brain structures including cerebral lobes, caudate nucleus, lentiform nucleus, thalamus, cerebel lar cortex, and brainstem. 
Magnetic Resonance Spectroscopy
MR investigations were performed using a 1.5-T MR system (Gyroscan Si 5, Philips). Localized spectra were obtained fol lowing conventional MR imaging using a 90-180-180 spinecho sequence with an echo time (TE) of 136 msec. Where applicable, additional measurements using echo times of 272 msec were performed to confirm peak assignment of lactate. . MRI at 20 months showed increased signal on the T 2-weighted image and de creased signal on the T r weighted image in the lateral putamen. MRS was normal. PET at 20 months re vealed a global decrease in glucose metabolism with markedly decreased values in the caudate nuclei, lentiform nuclei, thalamus, and frontal cortex (see Table 1 , Fig 1) . Electrophysiological studies were without ab normality. A muscle biopsy was unremarkable and no mitochondrial abnormalities were found (Table 3 ). An analysis for chromosomal defects was negative. The patient's condition progressively worsened and he died at the age of 2 years due to sepsis. The final clinical diagnosis was cerebral palsy due to an unidentified metabolic disorder. The lactic acidosis was probably caused by severe physical stress and exercise. Brain autopsy revealed a symmetrical glial poliodystrophy of cortex.
Case 2
The patient was the daughter of consanguineous parents (Grade I), born at term after normal pregnancy and delivery. At the age of 3 months she suffered a general ized seizure. At 5 months, she began having recurrent Table psychomotor retardation, movements, optic atrophy, and severe muscular hy potonia. MRI at 4 months showed cortical atrophy and widening of the cerebrospinal fluid (CSF) spaces. MRS of the right basal ganglia displayed decreased NAA 
Patients and Results
Fig 1, Transaxial metabolic maps at the basal ganglia level of all 4 patients obtained with 2-{!sF}fluoro-2-deoxyglucose posi tron emission tomography. The individual range of values (in fxmoll 100 gmlmin) displayed with a rainbow scale is shown be low each image, (Top row) Cases 2 and 3 with mitochondrial enzyme disorder and increased CM Rg/v, most pronounced in the basal ganglia. (Bottom row) Cases 1 and 4 without evidence of mitochondrial impairment and low metabolism.
the basal ganglia demonstrated increased lactate in the entire volume (Fig 2) . Evaluation with PET (see Fig  1) at 14 months showed remarkably increased meta bolic rates of glucose in all regions, with the largest increases in the caudate nuclei, lentiform nuclei, and parietooccipital cortex (see Table 1 ). Evoked potential (EP) studies were abnormal. Electroencephalogram (EEG) was slow without focal abnormalities. Electro myography (EMG) and nerve conduction velocity (NCV) examinations were normal. A muscle biopsy revealed a mild nonspecific myopathy. Analysis of mi tochondrial respiratory chain enzymes revealed a de fect in complex IV (cytochrome c oxidase). The pa- 
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Enzyme activities given in milliunits per mg protein (600 g of supernatanc was used in case of fresh muscle; total homogenate was used in case of frozen muscle). Citrate synthetase was used as mitochondrial reference enzyme. "Denotes post-mortem tissue. tient's condition deteriorated rapidly at the age of 18 thereafter cardiovascular formed Case 3 The patient was a term male newborn delivered spon taneously to consanguineous parents (Grade I) after an uncomplicated pregnancy. On the fifth day postpartum he developed hypotonia as well as increasing hypergly cemia and metabolic acidosis. He eventually required mechanical ventilation secondary to increasing respira tory insufficiency. At 7 days, he developed a severe lactic acidosis (see Table 2 ) and suffered generalized seizures. Magnetic resonance imaging (MRI) at 2 weeks revealed increased signal intensity predomi nantly on T 2-weighted images in the frontal lobes. MRS of the basal ganglia (Fig 3) revealed markedly decreased NAA/Cho and Cr/Cho ratios with a large lactate signal (8 ± 1 mmol/L). PET at 2 weeks demon strated globally elevated CM R^c in all regions with the largest increases in the thalamus, caudate and lenticular nuclei, and brainstem (see Table 1 ). EP studies sug gested a generalized central nervous system (CNS) dis turbance. EEG showed highly irregular background ac tivity with superimposed multifocal epileptic foci. Muscle biopsy was normal. Analysis of mitochondrial respiratory chain enzymes in skeletal muscle, and post m ortem studies of liver and brain tissue, revealed a defect in complex I (NADH-coenzyme Q t oxidoreductase) (see Table 3 ). A chromosome analysis was unremarkable. The child experienced a rapid decline during the third week and died on his 24th day due to cardiovascular collapse. Neuropachological examina tion revealed symmetrical spongy necrotizing lesions in both hemispheres, the basal ganglia, the thalamus, and the lower brainstem.
Case 4
The patient was the daughter of nonconsanguineous parents, born at term after an uneventful pregnancy and delivery. On the second day postpartum, she began experiencing cyanotic episodes that progressively in creased in frequency and later became associated with tonic-clonic movements of the arms and legs. Seizure like episodes decreased after the patient was treated with corticotropin (ACTH). She had hypotonia, tachyp nea, and increased respiratory tract sections. Labora tory tests were essentially normal. MRI was unremark able. MRS showed no abnormal metabolism products, but compared with other signals, NAA signal intensity was below normal level. PET at 1 month revealed a normal metabolic rate of glucose in all regions except for mildly decreased rates in the thalamus (see Table  1 ). Upon visual evaluation there was an area of in creased metabolism in the right mesiotemporal region that could have represented an epileptic focus. EEG showed multifocal spikes with alternating areas of focal epileptic activity in the right and left rolandic area. All other neurophysiologic studies were normal. A muscle biopsy and chromosome analysis were both normal. At 4 months she experienced a rather rapid decline chat was accompanied by tachycardia and tachypnea. There was a gradual increase in her arterial Pco2 over several days, which eventually required intubation, after intubation she developed asystole, which was re fractory to all resuscitative measures. Brain autopsy re vealed a right-sided frontoparietal polygyria as well as a moderate enlargement of the ventricular system. N e crosis was found in the area of the thalamus, lower brainstem, and bilateral occipital lobes.
Discussion
Results obtained from PET measurements on cerebral glucose metabolism and MRS provide evidence that patients with congenital lactic acidosis due to mito-to the massive increase of metabolism observed in Pa tient 3 with its maximum in the basal ganglia.
The extent of increase in the metabolic rates may depend on the type and severity of defect {26}.'The substantially higher rates of glucose metabolism and, correspondingly, the higher cerebral lactate concentra tion in Case 3 compared with Case 2 agree with the much more decreased activity of the respiratory chain capacity in Case 3. The cytochrome c oxidase activity in Patient 2's muscle was reduced only when expressed per citrate synthetase activity. In fibroblasts this en zyme showed a normal activity.
Glucose uptake and lactate accumulation are two as pects of glycolysis. The large resonance peaks for lac tate in Cases 2 and 3 show that high amounts of lactate were present in brain tissue but not in Cases 1 and 4. There was some contamination from CSF lactate signal, because the volumes of interest (VOIs) also contained 3.7500 3.0000 1
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parts of the ventricles (9% and 4% of total VOI in Cases 2 and 3, respectively). CSF concentrations mea sured by lumbar puncture (see Table 2 ) were in the same range (3-8 mmol/L) as values in the whole VOI, indicating that there were no large differences between tissue and CSF concentrations, and that the error of tissue concentration measurements due to CSF con tamination was small. Presence of lactate in the MR spectra seems to correlate with increased FDG uptake. This indicates that in these cases accumulated lactate is chondrial defects may have a globally accelerated state of cerebral glucose metabolism with relatively higher rates of metabolism in the thalamus and basal ganglia. Such high rates of metabolism are probably due to a change in the utilization of glucose: the cell's demand for energy cannot be covered by defective oxidative phosphorylation but initiates the glycolytic pathway in which glucose is catabolized to lactate for the produc tion of ATP. To compensate for the smaller yield of ATP per molecule of glucose from this process, the rate of glucose breakdown has to be much higher. The massive increase of glycolysis was observed in spite of a possible reduction of physiological C/VIi^k. due to sedation.
The relatively higher rates found in the basal ganglia and thalamus probably reflect the maturational changes in metabolism that are seen during early brain develop ment. Chugani and co-workers [12] described that the developmental increases in CMjRgk occur initially in the thalamus, the basal ganglia, and the sensorimotor cortex. Thus, the higher rates seen in these areas prob ably result because these structures begin developing first and express their defect earlier than other sur rounding structures. In principle, cortical epileptic dis charges, as recorded by EEG in Patients 3 and 4, could also contribute to the increase of C/Vfi?glc. In absence of an epileptic seizure such epileptic discharges may lead to small cortical hypermetabolic foci [25] , but not a consequence of increased glycolysis and does not re sult from impaired lactate clearance. In addition, the reductions in NAA in both Cases 2 and 3 suggest a process of ongoing neuronal damage. The low NAA signal in Case 4 may indicate neuronal damage or de layed myelination as a consequence of experienced cy anotic episodes.
Previous PET studies in adults with mitochondrial disorders showed globally decreased rates in metabo lism [3, 5, 6] . Two of these studies also demonstrated relatively larger decreases in the thalamus [5, 6] and basal ganglia [5] . Most likely that type of hypometabolism is the result of chronic brain damage. A similar was seen in our 1. Chronic energy ure has in a recent UP MRS study [27] . In one study [5] oxidative metabolism was compared with glucose metabolism and oxidation turned out to be relatively more impaired than glycolysis, probably still indicating increased nonoxidative glycolysis in that chronic stage. Possibly, our Patients 2 and 3 had a more severe form of the disease with a massive increase of glycolysis that could not be maintained for a long time. Theoretically, massive lactate accumulation could exert toxic effects [28] and thus contribute to the unfortu nate outcome; but increased cerebral lactate signals have also been described in chronic cases of mitochon drial encephalomyopathies [29] . PET and MRS now are able to demonstrate ; mec-abolic consequences of impaired mitochondrial respira tion noninvasively in brain tissue. Although mitochon drial diseases usually can be diagnosed by biochemical analysis of muscle biopsies, the severity of impairment may be different in muscle and brain, as indicated by our Case 2. Furthermore, the severeness of the clinical symptoms is often not well correlated with the residual activity of the affected enzyme. Therefore, with further experience, the imaging techniques may possibly pro vide an estimate of the severity of brain involvement and may permit diagnosis also in cases with little or no muscle involvement. In addition, effectiveness of therapy could be investigated by these techniques.
